Results 161 to 170 of about 39,875 (271)

Developing Public‐Friendly Visualisations to Improve PPIE Glossaries for Statistical Methodology Research

Health Expectations, Volume 29, Issue 3, June 2026.
ABSTRACT Background Plain‐language definitions help patients and the public engage in research, but some technical terms are easier to understand with visual aids. Furthermore, many people find visual aids more intuitive when learning new concepts.
Clareece R. Nevill, Hannah Cooper, Barbara Czyznikowska, Louise Fairgrieve, Justin Greenwood, Gurpreet Grewal‐Santini, Janion Nevill, Lucy Teece, Molly Wells, Suzanne C. Freeman, Sarah Booth   +10 more
wiley   +1 more source

Nrf2/NOX2 Pathway Dysregulation and Oxidative Stress Biomarkers in Gaucher Disease–Associated Parkinsonism: Insights Into a Potential Therapeutic Target

Journal of Cellular and Molecular Medicine, Volume 30, Issue 11, June 2026.
ABSTRACT Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder, yet its underlying genetic and molecular mechanisms remain incompletely understood. Variants in the GBA gene, encoding the lysosomal enzyme glucocerebrosidase, are not only responsible for Gaucher disease (GD) but also represent a significant genetic risk factor ...
Alessio Ardizzone, Marika Lanza, Anna Paola Capra, Giovanna Casili, Maria Bulzomì, Fabiola De Luca, Irene Paterniti, Michela Campolo, Emanuela Esposito   +8 more
wiley   +1 more source

Emerging Therapies in Duchenne Muscular Dystrophy: A Comparative Analysis of Gene Therapy and Pharmacological Approaches

Duchenne muscular dystrophy (DMD) is a progressive and severe X-linked recessive disorder characterized by progressive muscle weakness due to degeneration of muscle fibers resulting in a shortened life span.
Ninsiima , Karen Tukahirwa Jessica
core  

Refining the genetics of muscular dystrophies with defective glycosylation of dystroglycan

, 2010
The aberrant glycosylation of α-dystroglycan is associated with a subset of clinically heterogeneous muscular dystrophies collectively referred to as dystroglycanopathies.
Godfrey, C.
core  

Correction: Investigating the role of EGFR signalling in muscle dystrophies: implications for Duchenne muscular dystrophy. [PDF]

Cell Death Dis
Fernández-Simón E, Tejedera-Villafranca A, Fernández-Garabay X, Clark J, Monceau A, Villalobos E, Cox D, Azcón JR, Fernández-Costa JM, Diaz-Manera J.   +9 more
europepmc   +1 more source

Electrical Stimulation Use in Duchenne Muscular Dystrophy - An Evidence Based Analysis

, 2016
It is estimated that 1 in every 3,500-5,000 males born in the United States are born with Duchenne Muscular Dystrophy (DMD). DMD is a debilitating disease that progressively weakens skeletal, cardiac, and pulmonary muscles due to the lack of the protein ...
Lindsey F. Borders
core  

Gene Editing Strategies for Duchenne Muscular Dystrophy: From Molecular Mechanisms to Clinical Translation. [PDF]

Cells
Siddika A, Rousseau J, Veillette F, Bouchard C, Lu Y, Tremblay JP.   +5 more
europepmc   +1 more source

Ataluren for the treatment of people living with nonsense mutation Duchenne muscular dystrophy: a plain language summary of Study 041. [PDF]

J Comp Eff Res
Wu S, Vlodavets D, de Queiroz Campos Araujo AP, Castle J.   +3 more
europepmc   +1 more source

Conceptualization and design of an Ayurveda framework for the diagnosis of Duchenne Muscular Dystrophy: insights from a prospective cohort study. [PDF]

J Ayurveda Integr Med
Kumar S, Kannalayam R, Kakarla MS, Venugopal D, Raman LB.   +4 more
europepmc   +1 more source

Clinical Care and Rehabilitation in Neuromuscular Disorders-Why It Highly Matters. [PDF]

J Clin Med
Gdynia HJ.
europepmc   +1 more source